Safety lead
GSK, Wavre, Belgium
Wavre, Brabant Wallon, Belgium
Quentin Deraedt holds a PhD in chemistry from the Catholic University of Louvain, Belgium.
He is working on GSK vaccine projects since 2017. He first acted as publication coordinator supporting the delivery of congress materials and manuscripts mostly of clinical and epidemiological trials data. He then joined the GSK safety evaluation and risk management team as safety scientist supporting DTP-line products and is now the safety lead for Arexvy vaccine.
Disclosure(s): GSK: Salary as GSK employee, with stock options included, Stocks/Bonds (Public Company)
Saturday, October 19, 2024
2:39 PM – 2:59 PM US PT